- Research works
- 2 ▼ 10% vs 2013–17
- Citations
- 19 8.6 per fractional work
- Top-10% rate
- 19.2% record average 16.5%
- Open access
- 80% world 28%
Not ranked overall: Engimplan (Brazil) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Engimplan (Brazil) publish most on?
By volume in 2022–2025: Kidney Stones and Urolithiasis Treatments, Infectious Disease Case Reports and Treatments, Renal and Vascular Pathologies and Cardiovascular and exercise physiology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 0 works
- 2 Infectious Disease Case Reports and Treatments Infectious Diseases 0 works
- 3 Renal and Vascular Pathologies Pulmonary and Respiratory Medicine 0 works
- 4 Cardiovascular and exercise physiology Complementary and alternative medicine 0 works
- 5 Muscle Physiology and Disorders Molecular Biology 0 works
- 6 Sports Performance and Training Orthopedics and Sports Medicine 0 works
- 7 Breast Lesions and Carcinomas Pathology and Forensic Medicine 0 works
- 8 Breast Cancer Treatment Studies Cancer Research 0 works
- 9 Global Cancer Incidence and Screening Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Rio Claro
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.